Review of Venetoclax in CLL, AML and Multiple Myeloma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34073976/

Venetoclax is a highly selective and effective B-cell lymphoma-2 (BCL-2) inhibitor, which is able to reinstate the apoptotic potential of cancer cells. With its full repertoire yet to be explored, it has changed the therapeutic landscape in haematological malignancies, and most particularly chronic ...